Reducing Opioid Use After Total Hip Replacement
This study is looking at ways to manage pain after total hip replacement surgery while using fewer opioid pain medications. You could be eligible if you are an adult (18 or older) having a total hip replacement by a specific surgeon, and haven't used opioids chronically in the last three months. Participants will be randomly placed into one of two groups. One group gets the usual pain medication plan, with prescriptions sent to the pharmacy. The other group gets the same medications, but their opioid prescription (Tramadol) is a printed copy, meaning they decide if they want to fill it. The study will measure your pain and nausea levels, and how much opioid medication you use, up to three weeks after surgery.
- Study design
- This is an interventional study planning to enroll 100 participants. It compares two different approaches to pain management after total hip replacement.
- What's involved
- You will keep a pain journal and complete questionnaires about your medication intake for the first 21 days after surgery. You will also have follow-up visits over 3 months to assess your function and wellbeing.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants are followed for three months after surgery for function and wellbeing, and opioid consumption is tracked for three weeks post-op.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Multimodal Analgesic Regimen for Total Hip Arthroplasty: An Initiative to Minimize Postoperative Opioid Use
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michael Charters, MD · PRINCIPAL_INVESTIGATOR · Henry Ford Health System
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Postoperative Pain Score (Visual Analog Scale)Preoperative baseline through 3 weeks postoperatively
Pain severity measured using a visual analog scale (VAS) scored 0-10, where 0 represents no pain and 10 represents the worst possible pain. Scores collected preoperatively, daily during inpatient admission, daily for the first week post-discharge, then weekly for 2 additional weeks via patient pain journal and phone/text check-ins.
- Postoperative Nausea Score (Visual Analog Scale)Preoperative baseline through 3 weeks postoperatively
Nausea severity measured using a visual analog scale (VAS) scored 0-10, where 0 represents no nausea and 10 represents the worst possible nausea. Scores collected preoperatively, daily during inpatient admission, daily for the first week post-discharge, then weekly for 2 additional weeks via patient pain journal and phone/text check-ins.
- Opioid ConsumptionThree weeks post-op
Total opioid consumption measured in morphine milligram equivalents (MME) and by dose and quantity. Inpatient opioid use collected via electronic medical record and the Michigan Automated Prescription System (MAPS). Post-discharge opioid use recorded by the patient in a postoperative pain journal.
- Antiemetic Consumptionthree weeks postoperatively
Total antiemetic consumption recorded by dose and quantity. Inpatient use collected via electronic medical record; post-discharge use recorded by the patient in a postoperative pain journal.
- Length of Hospital StayPerioperative/Periprocedural
Total number of days from surgical admission to hospital discharge following primary total hip arthroplasty.
- Episodes of NauseaThree weeks postoperatively
Number of nausea episodes documented. Inpatient episodes collected via electronic medical record; post-discharge episodes recorded by the patient in a postoperative pain journal.